Jersey Chen, MD, MPH


Contemporary Use of Dual Antiplatelet Therapy for Preventing Cardiovascular Events

August 20, 2014

Use of dual antiplatelet therapy was modest for patients with existing cardiovascular disease for whom subgroup analysis from a landmark clinical trial suggested benefit in preventing cardiovascular events, and low for patients with multiple risk factors without established cardiovascular disease, for whom increased cardiovascular events were suggested.